KENYON LAWRENCE A — SEC Form 4 filings

SEC reporting owner CIK 1230484. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-03-22 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Outlook Therapeutics, Inc. (OTLK)Chief Financial Officer, Director42 legs · 106,010 sh · $28,4463

Form 4 filings — KENYON LAWRENCE A

FiledFormIssuerReported transactionsSource
2026-08-144Outlook Therapeutics, Inc. (OTLK)Purchase (P): 101,010 · Purchase (P): 101,010 (derivative)EDGAR
2026-07-234Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 210,078 (derivative) @ $0EDGAR
2024-09-304Outlook Therapeutics, Inc. (OTLK)Purchase (P): 5,000 @ $5.69EDGAR
2024-03-224Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 12,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1230484 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →